AKAP9 Antikörper (N-Term)
Kurzübersicht für AKAP9 Antikörper (N-Term) (ABIN925905)
Target
Alle AKAP9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Hund, Maus, Rind (Kuh)
-
Immunogen
- AKAP9 antibody was raised in rabbit using the N terminal of AKAP9 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
AKAP9 Blocking Peptide, (ABIN5611991), is also available for use as a blocking control in assays to test for specificity of this AKAP9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Andere Bezeichnung
- AKAP9
-
Hintergrund
- The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. AKAP9 is a member of the AKAP family. Alternate splicing of this gene results in many isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. Synonyms: Polyclonal AKAP9 antibody, Anti-AKAP9 antibody, A kinase, PRKA anchor protein, yotiao 9 antibody.
-
Pathways
- M Phase, SARS-CoV-2 Protein Interaktom
Target
-